500 related articles for article (PubMed ID: 32121304)
1. Contributions of DNA Damage to Alzheimer's Disease.
Lin X; Kapoor A; Gu Y; Chow MJ; Peng J; Zhao K; Tang D
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121304
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.
Haure-Mirande JV; Audrain M; Fanutza T; Kim SH; Klein WL; Glabe C; Readhead B; Dudley JT; Blitzer RD; Wang M; Zhang B; Schadt EE; Gandy S; Ehrlich ME
Acta Neuropathol; 2017 Nov; 134(5):769-788. PubMed ID: 28612290
[TBL] [Abstract][Full Text] [Related]
4. The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects.
Rocchi A; Orsucci D; Tognoni G; Ceravolo R; Siciliano G
Curr Alzheimer Res; 2009 Jun; 6(3):224-37. PubMed ID: 19519304
[TBL] [Abstract][Full Text] [Related]
5. Molecular Basis of Familial and Sporadic Alzheimer's Disease.
Dorszewska J; Prendecki M; Oczkowska A; Dezor M; Kozubski W
Curr Alzheimer Res; 2016; 13(9):952-63. PubMed ID: 26971934
[TBL] [Abstract][Full Text] [Related]
6. A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.
Atwood CS; Bowen RL
J Alzheimers Dis; 2015; 47(1):33-47. PubMed ID: 26402752
[TBL] [Abstract][Full Text] [Related]
7. Beta-amyloid, neuronal death and Alzheimer's disease.
Carter J; Lippa CF
Curr Mol Med; 2001 Dec; 1(6):733-7. PubMed ID: 11899259
[TBL] [Abstract][Full Text] [Related]
8. Tau load is associated with apolipoprotein E genotype and the amount of amyloid beta protein, Abeta40, in sporadic and familial Alzheimer's disease.
Thaker U; McDonagh AM; Iwatsubo T; Lendon CL; Pickering-Brown SM; Mann DM
Neuropathol Appl Neurobiol; 2003 Feb; 29(1):35-44. PubMed ID: 12581338
[TBL] [Abstract][Full Text] [Related]
9. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.
Lanoiselée HM; Nicolas G; Wallon D; Rovelet-Lecrux A; Lacour M; Rousseau S; Richard AC; Pasquier F; Rollin-Sillaire A; Martinaud O; Quillard-Muraine M; de la Sayette V; Boutoleau-Bretonniere C; Etcharry-Bouyx F; Chauviré V; Sarazin M; le Ber I; Epelbaum S; Jonveaux T; Rouaud O; Ceccaldi M; Félician O; Godefroy O; Formaglio M; Croisile B; Auriacombe S; Chamard L; Vincent JL; Sauvée M; Marelli-Tosi C; Gabelle A; Ozsancak C; Pariente J; Paquet C; Hannequin D; Campion D;
PLoS Med; 2017 Mar; 14(3):e1002270. PubMed ID: 28350801
[TBL] [Abstract][Full Text] [Related]
10. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
11. Neuron-specific methylome analysis reveals epigenetic regulation and tau-related dysfunction of BRCA1 in Alzheimer's disease.
Mano T; Nagata K; Nonaka T; Tarutani A; Imamura T; Hashimoto T; Bannai T; Koshi-Mano K; Tsuchida T; Ohtomo R; Takahashi-Fujigasaki J; Yamashita S; Ohyagi Y; Yamasaki R; Tsuji S; Tamaoka A; Ikeuchi T; Saido TC; Iwatsubo T; Ushijima T; Murayama S; Hasegawa M; Iwata A
Proc Natl Acad Sci U S A; 2017 Nov; 114(45):E9645-E9654. PubMed ID: 29042514
[TBL] [Abstract][Full Text] [Related]
12. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
14. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
15. DNA Double-Strand Break Accumulation in Alzheimer's Disease: Evidence from Experimental Models and Postmortem Human Brains.
Thadathil N; Delotterie DF; Xiao J; Hori R; McDonald MP; Khan MM
Mol Neurobiol; 2021 Jan; 58(1):118-131. PubMed ID: 32895786
[TBL] [Abstract][Full Text] [Related]
16. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
[TBL] [Abstract][Full Text] [Related]
17. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
Xu BG; Wu X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease.
Turner RS
Semin Neurol; 2006 Nov; 26(5):499-506. PubMed ID: 17048151
[TBL] [Abstract][Full Text] [Related]
19. Blood-brain barrier and innate immunity in the pathogenesis of Alzheimer's disease.
Šimić G; Španić E; Langer Horvat L; Hof PR
Prog Mol Biol Transl Sci; 2019; 168():99-145. PubMed ID: 31699331
[TBL] [Abstract][Full Text] [Related]
20. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease.
Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN
Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
